Purpose-built for physicians GLP-1 receptor agonists have changed the playing field in pediatric MASLD Key takeaways: Pediatric patients with MASLD experienced significant ALT reduction following treatment with GLP1-RAs
Louis found that GLP-1 medications were associated with lower risks of developing substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other substances
Additionally, there's Rybelsus, an oral form of the GLP-1 Receptor agonist is approved to treat type 2 diabetes
Slowed Stomach Emptying (Delayed Gastric Emptying): The medications slow down the rate at which food moves from the stomach into the small intestine
The simple serving format is designed for consistency and everyday use
This is the origin of cancer